Sameer Mahesh | Biological Therapy/Immunotherapy Biological Therapy/Immunotherapy Chemotherapy Pain Management Targeted Therapy

Sameer Mahesh, MD

Medical Oncologist

Conditions Treated

Laryngeal Cancer Lung Cancer Ovarian Cancer Pericardial Mesothelioma Peritoneal Mesothelioma Testicular Mesothelioma

specialties & services

Biological Therapy/Immunotherapy Biological Therapy/Immunotherapy Chemotherapy Pain Management Targeted Therapy

Hospitals & Clinics

Bio & Insurance Information

Insurance Accepted

Aetna Choice POS II Aetna HMO First Health PPO

Education & Training

St Luke's-Roosevelt Hospital Center

Residency

Albert Einstein College of Medicine

Fellowship

Topiwala National Medical College

Medical School

Board Certifications

American Board of Internal Medicine

American Board of Internal Medicine - Hematology

American Board of Internal Medicine - Oncology

Medical License

OH State Medical License Active through 2018

Hospitals & Clinics

Publications

Dr. Sameer Mahesh has contributed to 3 publications.

The BRAF mutation in MLH1-deficient colorectal cancer

Mahesh, S. A.; Clin Adv Hematol Oncol. 2013 Apr.

Intratracheally administered 5-azacytidine is effective against orthotopic human lung cancer xenograft models and devoid of important systemic toxicity.

Mahesh, S.,Saxena, A.,Qiu, X.,Perez-Soler, R.,Zou, Y.; Clin Lung Cancer. 2010 Nov 11.

Hepatosplenic gamma-delta T-cell lymphoma presenting with disseminated intravascular coagulation and coexistent systemic mastocytosis.

Jahangiri S, Mahesh S; Clin Adv Hematol Oncol. 2010-10-01.